Relationships Between Diabetes Mellitus Type 2 and Male Testosterone Level
|
|
- Beverly Curtis
- 8 years ago
- Views:
Transcription
1 Relationships Between Diabetes Mellitus Type 2 and Male Testosterone Level Afaf Khairey Esmaeel Dept. of Biology, Faculty of Science, Babylon University, Iraq. Abstract The objective of the present study was to verify if there is any relation between diabetes mellitus type 2 and male testosterone concentration. Ten diabetic men in the age group (25-53) year were selected. Ten healthy men in the same age group served as control. The result show no significant changes (P>0.05) was found in testosterone level of diabetic patients when compared with testosterone level of control. الخلاصة الهدف من الد ارسة الحالیة هو معرفة فیما أذا كانت هناك علاقة ما بین مرض السكري من النوع الثاني وتركیز هرمون الشحمون الخصوي في الرجال. تم انتخاب عشرة رجال مصابین بمرض السكري من النوع الثاني وعشرة رجال أصحاء تت اروح أعمارهم ما بین ٢٥-٥٣ سنة. أظهرت النتاي ج عدم وجود فروق معنویة (0.05<p) في تركیز هرمون الشحمون الخصوي للمصابین بمرض السكري عند مقارنتهم مع مجموعة السیطرة. Introduction Diabetes mellitus is a chronic disorder of the carbohydrate, lipid and protein metabolism characterized by insulin disorders, hyperglycemia and glycosuria. This condition may contribute to arteriosclerosis, microangiopathy, nephropathy and neuropathy (Camilleri, 2007). Although most problems due to diabetes have been widely studied, the reproductive system affections are still little understood (Zarzycki & Zieniewics, 2005). Diabetes mellitus has been associated with sexual dysfunction in both men and women. It is believed that neuropathy, vascular insufficiency and psychological problems may be involved in the pathogenesis of some phenomena such as impotence, ejaculation disorders and decreased libido, in addition to the reduced vaginal lubrication and orgasm dysfunctions (DeBerardis et al., 2007; Zarzycki and Zieniewics; 2005). Some studies show that diabetic patients infertility caused by inappropriate synthesis of testosterone, caused by molecular changes in Leydig cells, secondary to diabetes (Dinulovic and Radonjic, 1990). Testosterone is the principal male sex hormone and anabolic steroid. In men, testosterone plays a key role in development of male reproductive tissues such as the testes and prostate as well as promoting secondary sexual characteristics such as increased muscle and bone mass and hair growth (Tuck and Francis,2009).Male testosterone is primarily synthesized in Leydig cells, the number of Leydig cells in turn is regulated by luteinizing hormone (LH)and follicle stimulating hormone (FSH). in addition, the amount of testosterone produced by existing Leydig cells is under the control of LH which regulates the expression of 17-B hydroxyl steroid dehydrogenase (Payne and O'shaughnessy, 1996). Testosterone is present in three major fractions: free (2-3%), albumin-bound (20-40%), and sex hormone binding globulin (SHBG)-bound (60-80%). Non-SHBGbound testosterone is called bioavailable testosterone because both the free and albumin-bound fractions comprise the biologically active component that is readily ٥٦
2 available to the tissues, whereas SHBG-bound testosterone is tightly bound and thus considered inactive. A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (Dhindsa, 2004). The relation between male infertility and altered plasma levels of testosterone is still obscure (Ballester et al., 2004). Maneesh et al. (2006) show that low serum testosterone in diabetic men was accompanied with low serum LH & FSH and suggested that the hypothalamic cells, which produce LHRH, do not function correctly to the feedback when testosterone level decreased, this inability of pituitary gland to respond appropriately to decline in testosterone implies that high serum glucose has a central effect on the interaction between the nervous system and endocrine system, the decrease in serum LH and FSH may result from impairment in its production and secretion. Obesity is associated with low testosterone levels in diabetic men, the increase in body lipids decreases serum testosterone level due to increased activity of the aromatase enzyme present in fat tissues there by converting testosterone and androstendione to estrogens. Consequently in diabetic men, in addition to decreased testosterone production and metabolism, higher than normal percentages of testosterone and androstenedione are converted into eastradiol and estrone, respectively. This increased conversion may account for the diminished testosterone. The increased estrogens appear to exert a negative feedback effect on LH and FSH production and may thereby contribute to the alcoholic suppression of these reproductive hormones. Also they found significantly low serum testosterone with low LH and FSH, they were suggest that the low serum testosterone levels decreased, levels of LH and FSH would increase to stimulate the production of more testosterone. On the other hand, Miralles-Garcia et al., (2004) found that insulin-dependent diabetes is associated with reduced ejaculated semen and decreased vitality & motility of the spermatozoa, with no change in sperm viscosity. Insulin action in motility and in the metabolism of human spermatozoa is not defined. Defects in insulin secretion may change testicular and accessory sexual glands function. Usually, the concentration of seminal insulin is higher than that in the serum (Chandrashekar & Bartke, 2005). A recent systematic review and meta-analysis of cross-sectional studies indicated that testosterone levels were significantly lower in men with type 2 diabetes (Ding et al., 2006). Svartberg (2007) was founded that men with type 2 diabetes have a lower serum testosterone concentration compared to men without a history of diabetes, and there is an inverse association between testosterone levels and hemoglobin A (HbAIc) concentrations. Further, in men with low plasma testosterone the risk of diabetes mellitus is increased (Zitzmann et al,. 2006). One-third to one half of men with type 2 diabetes mellitus are now recognized as testosterone deficient (Spark, 2007). A low plasma testosterone level appeared to be associated with endothelial dysfunction in men independent of other risk factors, suggesting a protective effect of endogenous testosterone on the endothelium (Akishita et al., 2007). In addition, serum endogenous androgen concentrations were inversely associated with arterial stiffness in men with type 2 diabetes mellitus (Fukui et al.,2007). There is an association of type 2 diabetes with low testosterone values, and therefore the effects of an intervention with testosterone are of considerable interest, ٥٧
3 in hypogonadal men, the few studies on the effects of testosterone treatment on glycemic control were divergent (Basu, 2007). Kalinchenko et al., (2009) were demonstrated that the beneficial effects of administration of testosterone to hypogonadal with a diabetic foot may be due to improved vascularization & to anti-inflammatory action. Methods Twenty male subjects aged years were prospectively studied and classified as group 1 (n=10) healthy individuals, group 2 (n=10) men with diabetes mellitus type 2. Serum testosterone was estimated for all samples by direct immunoezymatic method using reagent kit (testosterone enzymeimmunoassay test kit, catalog Number: Bc -1115, Biocheck, 837 CowanRd, Burlingame, CA, 94010). Collection of specimens Venous blood samples were obtained from all subjects by using disposable syringes and needles, samples were allowed to clot at 37 o C, then centrifuged at 3000 Xg for 15 minutes. Sera were removed and stored at 2 8 o C. Assay of procedure 1. Secure the desired number of coated wells in the holder. 2. Dispense 10 µl of standards, specimens and controls into appropriate wells. 3. Dispense 100 µl of testosterone-hrp conjugate regeant into each well. 4. Dispense 50 µl of rabbit anti-testosterone reagent to each well. Thoroughly mix for 30 seconds. It is very important to mix completely. 5. Incubate at 37 ºC for 90 minutes. 6. Rinse and flick the microwells 5 times with distilled. 7. Dispense 100 µl of TMB reagent into each well. Gently mix for 5 seconds. 8. incubate at room temperature (18-25 ºC) for 20 minutes. 9. Stop the reaction by adding 100 µl of stop solution to each well. 10. Gently mix 30 seconds. It is important to make sure that all the blue color changes to yellow color completely. 11. Read absorbance at 450 nm with a microtiter well reader within 15 minutes. Results 1. Testosterone level between control and diabetic patients The results show no significant differences (P>0.05) in testosterone level in diabetic patients group as compared with control group as figure (1). Testosterone level (ng/ml) control group Diabetic group t (0.05) =0.139 Figure (1): Testosterone level (ng/ml) of control and diabetic patients. ٥٨
4 2. Relationship between testosterone (ng/ml) and duration of disease in diabetic patients The results revealed no strong correlation between testosterone (ng/ml) and duration of diabetes mellitus type 2 in our study. Serum testosterone level (ng/ml) r= Duration of disease (day) Figure (2): The relationship between testosterone (ng/ml) and duration of disease in diabetic patients. 3. Relationship between testosterone (ng/ml) and blood glucose (mg/100 ml) in diabetic patients There is no strong correlation between testosterone (ng/ml) and blood glucose in type 2 diabetic men in our study serum testosterone level (ng/ml) Blood glucose (mg/100 ml) r= Figure (3): Relationship between blood glucose (mg/100 ml) and serum testosterone level (ng/ml). Discussion The results show no significant differences in testosterone levels between the control group and diabetic men group. Also other studies did not demonstrate altered serum testosterone levels among diabetics, regardless of their sexual performance (Bolona et al., 2007; Ballester et al., 2005). Previous studies showed that about onethird of type 2 diabetic men have low serum testosterone levels because of a high prevalence of symptomatic hypogonadism (Kapoor et al., 2007). Other studies showed that low serum testosterone could be due to decreased synthesis or increased metabolic clearance (Cevik et al., 2004). Testosterone deficiency in diabetic men may because of the level of sex hormone binding globulin (SHBG) the major carrier protein of testosterone in circulation is low as a consequence of insulin resistance ٥٩
5 (Andersson et al., 1994). Dhindsa et al., (2004) demonstrated that 33% (not all) of men with type 2 diabetes had significantly lower levels of free testosterone. The question thus arises as to why diabetic men have lower testosterone levels, the answer was Klinefelter's syndrome, the most frequent form of primary hypogonadism, is associated with insulin resistance and diabetes (Ota et al., 2002). Dhindsa et al., (2007) found that free testosterone was diminished in diabetic patients with organic importance. This is not found in the non-impotent diabetes. Male impotence which consists in difficulty in obtaining or maintaining full erection until the end of coitus, is a common sexual problem in diabetics (De Berardis et al., 2007; Miralles-Garcia & Garcia-Diez, 2004). The prevalence of this complaint ranges from 20-50%, increasing with patient age and duration of the disease (Petroianu et al., 2009; Chandrashekar & Bartke, 2005). Bolona et al., (2007) stated that impotence is a multifactorial sexual disorder, secondary to endocrine, vascular, neurological and psychological disorders which act unfavorably on erection. Petroianu et al., (2009) observed that vascular and neuronal anomalies as the causes of impotence in diabetic patients. On other hand, hormones did not significantly affect this dysfunction. In 2005, Pitteloudet observed that the leydig cell population and testosterone metabolites were reduced, which was inversely related to the increase of insulin resistance. Ding et al., (2006) were indicated that endogenous sex hormones may differentially modulate glycemic status and risk of type 2 diabetes in men & women. Low testosterone levels are associated with higher risk of type 2 diabetes in men but with lower risk in women. Selvin et al., (2007) were suggested that testosterone insufficiency may be a risk factor for diabetes. So the associations of low free bioavailable testosterone levels with diabetes remained even after adjustment for age & known confounding factors including race/ethnicity & adiposity as measured by body mass index (BMI) and waist-to-hip ratio. References Akishita M; Hashimoto M; Ohike Y; Ogawa S; Lijma K; Eto M; Ouchi Y. (2007). Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res., 30 (11): Andersson, B.; Marin, P.; Lissner, L.; Vermeulen, A.; Bjorntorp, P. (1994). Testosterone concentrations in women and men with NIDDM. Diabetes Care, 17: Ballester J; Munoz MC; Dominguez J; Rigau T; Guinovart JJ; Rodriguez-Gil JE. (2004). Insulin-dependent diabetes affects testicular function by FSH- and LHlinked mechanisms. J. Androl., 25 (5): Basu R; Dalla Man C; Campini M; Basu A; Nair KS; Jensen MD; Khosla S; Klee G; Toffolo G; Cotelli C. (2007). Effects of two years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance and post prandial glucose turnover I elderly men. Bhasin S; Enzlin P; Coviello A; Basson R. (2007). Sexual dysfunction in men and women with endocrine disorders. Lancet., 369 (9561): Bolona ER; Uraga MV; Haddad RM; Tracz MJ; Sideras K; Kennedy CC. (2007). Testosterone use in men with sexual dysfunction: a systematic review and metaanalysis of randomized placebo-controlled trials. Mayo. Clin. Proc. 82 (1): ٦٠
6 Camilleri M. (2007). Clinical practice. Diabetic gastroparesis. N Engl. J. Med., 356 (8): Cevik R ; Gur A ; Acar S ; Nas K; Sarac A. J. (2004). Hypothalamic pituitaeygonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones. BMC Musculoskelet. Disord., 5: Chandrashekar V; Bartke A. (2005). The impact of altered insulin-like growth factor- 1 secretion on the neuroendocrine and testicular functions. Minerva Ginecol., 57 (1): De Berardis G.; Pellegrini F.; Franciosi M.; Belfiglio M. & Di Nardo B. (2007). Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes. J. Urol., 177 (1): Dhindsa S; Prabhakar S; Sethi M; Bandyopadhyay A; Chaudhuri A; Dandona P. (2004). Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J. Clin. Endocrinol. Metab., 89: Ding EL; Song Y; Malik VS; Liu S. (2006). Sex differences of endogenous sex hormones and risk of type 2 diabetes. American Medical Association, vol. 295, No. 11. Dinulovic D. & Radonjic G. (1990). Diabetes mellitus/male infertility. Arch. Androl., 25 (3): Fukui M; Ose H; Kitagawa Y; Yamazaki M; Hasegawa G; Yoshikawa T; Nakamura N. (2007). Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus. Metabolism, 56 (9): Kalinchenko S; Zemlyanoy A; Gooren LJ. (2009). Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease-report of three cases. Cardiovascular diabetology, 8: 19. page 1 to 6. Kapoor D; Aldred H; Clark S; Channer KS; Jones H. (2007). Clinical andbiochemical assessment of hypogonadism in men with type 2 diabetes. Diabetes care, volume 30, number 4. Maneesh M; Jayaiekshmi H; Sanjiba Dutta; Amit Chakrabarti and Vasudevan DM. (2005). Effect of chronic ethanol administration on testicular antioxidant system and steroidogenic enzyme activity in rats. Indian J. Exp. Boil. (In press). Maneesh M; Jayalakshmi H; Singh TA; Amit Chakrabarti (2006). Impaired hypothalamic-pituitary gonadal axis function in men with diabetes mellitus. Indian Journal of Clinical biochemistry, 21 (1): Miralles-Garcia JM; Garcia-Diez LC. (2004). Specific aspects of erectile dysfunction in endocrinology. Int. J. Impot. Res. 16 (Suppl. 2): S Ota K.; Suehiro T.; Ikeda Y; Arii K; Kumon Y; Hashimoto K. (2002). Diabetes mellitus associated with Klinefelter's syndrome: a case report and review in Japan. Intern. Med., 41: Payne AH; O'Shaughnessy P. (1996). Structure, function, and regulation of "steroidogenic enzymes in the Ledig cell". In Payne AH, Hardy MP, Russell LD. Ledig cell. Vienna [11]: Cache River press pp Petroianu A; Alberti LR; Melo MAB; Almeida LM. (2009). Relation between diabetes mellitus and male fertility. Einstien 7 ( 4 pt 1): Pitteloud N; Hardin M; Dwyer AA; Valassi E; Yialamas M; Elahi D. (2005). Increasing insulin resistance is associated with a decrease in leydig cell testosterone secretion in men. J. Clin. Endocrinol. Metab., 90 (5): ٦١
7 Selvin E ;Feineib M ;Zhang L ;Rohrman S;Rifai N ;Nelson W ;Dobs A ;Basaria S ;Golden S. H ;Platz E.A.(2007).Androgen and diabetes in men.diabetes Care,volume 30 number 2 : Spark RF.(2007). Testosterone, diabetes mellitus, and the metabolic syndrome. Curr. Urol. Rep., 8 (6): Svartberg J. (2007). Epidemiology: testosterone and the metabolic syndrome. Int. J. Impot. Res., 19 (2): Tuck SP & Francis RM (2009). Testosterone, bone and osteoporosis. Front Horm Res., 37: Zarzycki W.; Zieniewicz M. (2005). Reproductive disturbances in type 1 diabetic women. Neuro Endocrinol Lett., 26 (6): Zitzmann M; Fater S; Nieschlag E. (2006). Association of specific symptoms and metabolic risks with serum testosterone in older men. J. Clin. Endocrinol. Metab. 91 (11): ٦٢
Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome
Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual
More informationFocus. Andropause: fact or fiction? Introduction. Johan Wilson is an Auckland GP KEY POINTS
1 of 5 Focus Andropause: fact or fiction? Johan Wilson is an Auckland GP Introduction Androgen deficiency in the ageing male, or andropause, is being diagnosed with increased frequency. A growing body
More informationEndocrine Responses to Resistance Exercise
chapter 3 Endocrine Responses to Resistance Exercise Chapter Objectives Understand basic concepts of endocrinology. Explain the physiological roles of anabolic hormones. Describe hormonal responses to
More informationContinuity Clinic Educational Didactic. December 8 th December 12 th
Continuity Clinic Educational Didactic December 8 th December 12 th MKSAP Question 1 A 60-year-old man is evaluated for a 1-year history of generalized fatigue and lack of energy. He has had erectile dysfunction
More informationHypogonadism and Testosterone Replacement in Men with HIV
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Hypogonadism and Testosterone Replacement in Men with HIV Stephanie T. Page, MD, PhD Robert B. McMillen Professor in Lipid Research, Associate Professor of
More informationPrevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus
Prevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus Hypogonadism is defined as deficient or absent male gonadal function
More informationGuidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
More informationHypogonadism and Subnormal Total Testosterone Levels in Men with Type 2 Diabetes Mellitus
ORIGINAL ARTICLE Hypogonadism and Subnormal Total Testosterone Levels in Men with Type 2 Diabetes Mellitus Okeoghene Anthonia Ogbera 1, Chinenye Sonny 2, Fasanmade Olufemi 3 and Ajala Wale 4 ABSTRACT Objective:
More informationtestosterone_pellet_implantation_for_androgen_deficiency_in_men 10/2015 N/A 11/2016 10/2015 This policy is not effective until December 30, 2015
Corporate Medical Policy Testosterone Pellet Implantation for Androgen Deficiency in File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testosterone_pellet_implantation_for_androgen_deficiency_in_men
More informationFACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN
FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN General Pantarhei Bioscience B.V. is an emerging specialty pharmaceutical company with a creative approach towards drug development. The Company
More informationTestosterone Replacement Therapy. Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division
Testosterone Replacement Therapy Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division Lecture Outline 1. Anatomy and physiology 2. Definition and etiology 3. Signs and symptoms
More informationTestosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS
Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS The faces of Low Testosterone What your patients are seeing Pharmacy Industry Testosterone
More informationCurrent Data and Considerations Novel Testosterone Formulations
Current Data and Considerations Novel Testosterone Formulations 1 Diagnosis and Assessment Module 2 2 Objectives Identify clinical manifestations and symptoms of hypogonadism Describe components of comprehensive
More informationMENOPAUSE WOMAN'S TEST (Assessment of hormone balance)
ATTACHMENT: Useful remarks for patient and doctor, to be associated to the analytical results. Your doctor should interpret this report. Cod. ID: 123456 CCV: 6bf Date: 01/01/2013 Patient: Rossi Mario Rapport
More informationThe ABC s and T s of Male Infertility
The ABC s and T s of Male Infertility Men s Health Initiative of BC - Focus on Testosterone Ethan D. Grober, MD, MEd, FRCSC Assistant Professor University of Toronto Department of Surgery, Division of
More informationTestosterone: Is Just for the GOP?
Testosterone: Is Just for the GOP? Brad Anawalt, MD Vice Chair and Professor of Medicine University of Washington May 1, 2015 banawalt@medicine.washington.edu Testosterone continuum Severe hypogonadism
More informationThe Testosterone Report
The Testosterone Report Contents 1. What is Testosterone? 2. Why is Testosterone necessary? 3. Why do my Testosterone Levels decrease? 4. What does low Testosterone cause? 5. How Do I raise my Testosterone?
More informationTestosterone in Old(er) Men
Testosterone in Old(er) Men Disclosure Information J. Bruce Redmon, M.D. Associate Professor Division of Endocrinology I have no financial relationships to disclose. I will not discuss off label use and/or
More informationTestosterone Treatment: Myths Vs Reality. Fadi Al-Khayer, M.D, F.A.C.E
Testosterone Treatment: Myths Vs Reality Fadi Al-Khayer, M.D, F.A.C.E The Biological Functions of Testosterone in Men Testosterone is essential to the musculoskeletal and metabolic systems throughout a
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME
1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR INSULIN RESISTANCE, POLYCYSTIC OVARIAN
More informationShira Miller, M.D. Los Angeles, CA 310-734-8864 www.shiramillermd.com. The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library
Shira Miller, M.D. Los Angeles, CA 310-734-8864 The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library 2 Outline What is hormone therapy? Why would healthy men and women need to think about
More informationBIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE
Authoriser: Moya O Doherty Page 1 of 7 BIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE The purpose of this protocol is to describe common tests used for the investigation
More informationSex Hormone Testing by Mass Spectrometry
Sex Hormone Testing by Mass Spectrometry Robert L. Fitzgerald, PhD, DABCC Professor of Pathology University of California-San Diego San Diego, CA, 92161 rfitzgerald@ucsd.edu Learning Objectives After this
More informationTestosterone and Heart Disease
Testosterone and Heart Disease By Pamela W. Smith, M.D., MPH, MS Introduction Two recent trials suggest that testosterone replacement therapy may increase the risk of heart disease and/or stroke. 1, 2
More informationMEASUREMENT OF TESTOSTERONE Roland R. Tremblay
MEASUREMENT OF TESTOSTERONE Roland R. Tremblay Learning Objectives 1. To understand that andropause is constituted by two structural levels and that the surface structure is amenable to diagnosis and treatment.
More informationVaricocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD
Varicocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD Professor and Chairman, Department of Urology, Cleveland Clinic Lerner College of Medicine; Cleveland, Ohio Objectives: Review
More informationAre Men Losing Their Gonads?
Are Men Losing Their Gonads? Andre B. Araujo, Ph.D. Director, Epidemiology New England Research Institutes Watertown, MA 02472 USA aaraujo@neriscience.com NIA R01AG020727 Endocrine Society Annual Meeting
More informationGUIDELINES ON MALE HYPOGONADISM
GUIDELINES ON MALE HYPOGONADISM G.R. Dohle (chair), S. Arver,. Bettocchi, S. Kliesch, M. Punab, W. de Ronde Introduction Male hypogonadism is a clinical syndrome caused by androgen deficiency. It may adversely
More informationFunctional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE
Functional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE Interpretation and treatment: male hormone profile By Ron Grisanti, D.C. & Dicken Weatherby, N.D. http://www.functionalmedicineuniversity.com
More informationAge Management Panel Male Fasting Panel
801 SW 16th St Suite 126 Renton WA 98057 Phone: 425.271.8689 Fax: 425.271.8689 CLIA # 50D0630590 Age Management Panel Male Fasting Panel Doctor ID 1001 Age 55 Date Collected 01/01/07 Patient Name DOE,
More informationEndocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER
Endocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER 80% of children and adults with FA have an endocrine abnormality Endocrine cells make a hormone (message) Carried in bloodstream
More informationMale Health. The three major issues are: Cardiovascular Health Prostate Health Fertility & Sexual Performance
Male Health Do Men Value Their Health? The ancient Greek physician Hippocrates once said, A wise man ought to realise that his health is his most valuable possession. It is believed that Hippocrates lived
More informationTestosterone for women, who when and how much?
Medicine, Nursing and Health Sciences Testosterone for women, who when and how much? Susan R Davis MBBS FRACP PhD Women s Health Research Program School of Public Health Monash University Melbourne Medicine,
More informationTHE ROLE OF FREE TESTOSTERONE COMPARATIVE WITH TOTAL TESTOSTERONE IN MALE PATIENTS WITH ERECTILE DYSFUNCTION
THE ROLE OF FREE TESTOSTERONE COMPARATIVE WITH TOTAL TESTOSTERONE IN MALE PATIENTS WITH ERECTILE DYSFUNCTION Porav-Hodade Daniel 1, Coman Ioan 2, Boja Radu M 1, Todea Ciprian 1, Georgescu Carmen 2, Crisan
More informationCARDIOMETABOLIC DISEASE AND TESTOSTERONE DEFICIENCY: IS THERE A LINK?
CARDIOMETABOLIC DISEASE AND TESTOSTERONE DEFICIENCY: IS THERE A LINK? Abraham Morgentaler, MD Founder and Director, Men s Health Boston Associate Clinical Professor of Urology Beth Israel Deaconess Medical
More informationDefinitions. Androgen deficiency. Clinical Hypogonadism* Low serum testosterone level Also called biochemical hypogonadism
MALE HYPOGONADISM Mark Sigman Krishnamurthi Family Professor and Chief of Urology Warren Alpert Medical School of Brown University Chief of Urology Rhode Island and the Miriam Hospitals 1 Topics What is
More informationScientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation
Annex II Scientific conclusions and grounds for variation to the terms of the marketing authorisations subject to conditions and detailed explanation of the scientific grounds for the differences from
More informationFree Testosterone Cat# 2924Z
See external label 2 C-8 C Σ=96 tests Cat # 2924Z Free Testosterone Cat# 2924Z Direct immunoenzymatic determination of Free Testosterone in serum or plasma. For in vitro diagnostic use only INTENDED USE
More informationMale Hypogonadism. Hypogonadism is characterised by impaired testicular function, which may affect spermatogenesis and/or testosterone synthesis.
L APPROCCIO MEDICO AL PAZIENTE AZOOSPERMICO Marco Rossato Università degli Studi di Padova Dipartimento di Medicina - DIMED Clinica Medica 3 Direttore: prof. Roberto VETTOR Male Hypogonadism Hypogonadism
More informationX-Plain Low Testosterone Reference Summary
X-Plain Low Testosterone Reference Summary Introduction Testosterone is the most important male sex hormone. It helps the body produce and maintain adult male features. Low levels of testosterone affect
More informationFebruary 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS
February 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS Calvin Hirsch, MD Professor of Clinical Internal Medicine (Geriatrics) UC Davis School of
More informationUs TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy
Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Today s speaker is Samir Taneja, MD Program moderator is Pam Barrett, Us TOO International Made possible
More informationHormone Replacement Therapy For Men Consultation Information. Round Rock Jollyville Westlake 512-231-1444 www.urologyteam.com.
Hormone Replacement Therapy For Men Consultation Information Round Rock Jollyville Westlake 512-231-1444 www.urologyteam.com Rev 05/13 Table of Contents Biological Aging and Hormones 2 As we age.... 3
More informationPrevalence and Characteristics of Low Serum Testosterone Levels in Men with Type 2 Diabetes Mellitus Naïve to Injectable Therapy
Prevalence and Characteristics of Low Serum Testosterone Levels in Men with Type 2 Diabetes Mellitus Naïve to Injectable Therapy International Society for Sexual Medicine 2014 Presenter: Felipe Borges
More informationHormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions
Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions IMPORTANCE OF HORMONE BALANCE Importance of Hormone Balance Help you live a long, healthy life Help you
More informationDisability Evaluation Under Social Security
Disability Evaluation Under Social Security Revised Medical Criteria for Evaluating Endocrine Disorders Effective June 7, 2011 Why a Revision? Social Security revisions reflect: SSA s adjudicative experience.
More informationMMM. Topic Diagnosis and Testosterone Replacement Therapy for Androgen Deficiency in the Aging Male (ADAM)
Dr Tan & Partners MMM Vol. 1 No. 3 Morbidity & Mortality Meeting 12 th December 2014 Topic Diagnosis and Testosterone Replacement Therapy for Androgen Deficiency in the Aging Male (ADAM) Introduction Androgen
More information(Received 12th June 1968)
PLASMA LEVELS OF TESTOSTERONE IN MALE RABBITS FOLLOWING COPULATION GARY C. HALTMEYER and KRISTEN B. EIK-NES Department of Physiology, Division of Physiology and Biochemistry of Reproduction, University
More informationTYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
More informationTestosterone Treatment in Older Men
Testosterone Treatment in Older Men J. Bruce Redmon, M.D. Professor Division of Endocrinology Departments of Medicine and Urologic Surgery Disclosure Information I have no financial relationships to disclose.
More informationAndrogens and CVD. Brandon Orr- Walker April 2014
Androgens and CVD Brandon Orr- Walker April 2014 Agenda What is normal physiology of Aging? Hypogonadism and disease If some is good is more becer? CVD safety Clinical features of Androgen Deficiency
More informationmale sexual dysfunction
male sexual dysfunction lack of desire Both men and women often lose interest in sex during cancer treatment, at least for a time. At first, concern for survival is so overwhelming that sex is far down
More informationAdrenal Function Graph
105-32 Royal Vista Dr NW Calgary, AB T3R 0H9 Website: www.rmalab.com Phone: 403-241-4500 Fax: 403-241-4501 Email: info@rmalab.com Collection Date: 20-Jan-2014 Collection Time(s): 7:15 am 12:30 pm 8:00
More informationPrevalence of erectile dysfunction among Saudi type 2 diabetic patients
European Review for Medical and Pharmacological Sciences Prevalence of erectile dysfunction among Saudi type 2 diabetic patients A. HASSAN, K. ABURISHEH, T.J. SHEIKH, S.A. MEO 1, N.A. AHMED 1, A.H. AL
More informationDeficient testosterone levels in men above 45 years with major depressive disorder an age-matched case control study
Deficient testosterone levels in men above 45 years with major depressive disorder an age-matched case control study A M Dikobe, MB ChB, MMed (Psych) C W van Staden, MB ChB, MMed (Psych), MD, FCPsych,
More informationINFERTILITY/POLYCYSTIC OVARIAN SYNDROME. Ovulatory Dysfunction: Polycystic ovarian syndrome (PCOS)
Introduction Infertility is defined as the absence of pregnancy following 12 months of unprotected intercourse. Infertility may be caused by Ovulatory Dysfunction, Blocked Fallopian Tubes, Male Factor
More informationRegulation of Metabolism. By Dr. Carmen Rexach Physiology Mt San Antonio College
Regulation of Metabolism By Dr. Carmen Rexach Physiology Mt San Antonio College Energy Constant need in living cells Measured in kcal carbohydrates and proteins = 4kcal/g Fats = 9kcal/g Most diets are
More informationIntroduction. Pathogenesis of type 2 diabetes
Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic
More informationTestosterone Testing
20, 2012 Health Technology Assessment Testosterone Testing Final Evidence Report February 6, 2015 Health Technology Assessment Program (HTA) Washington State Health Care Authority PO Box 42712 Olympia,
More informationANDROPAUSE. Male Menopause
Male Menopause Male Hormones and Aging As men age past year 40, hormonal changes occur that perceptibly inhibit physical, sexual, and cognitive function. The outward appearance of a typical middle-aged
More informationTRIIODOTHYRONINE (T3) ELISA Kit Protocol
TRIIODOTHYRONINE (T3) ELISA Kit Protocol (Cat. No.:EK-310-05) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED USE For the
More informationABCD position statement on the management of hypogonadal males with type 2 diabetes
PS ABCD hypogonadism_layout 1 10/11/2010 16:59 Page 1 ABCD position statement on the management of hypogonadal males with type 2 diabetes K Dhatariya*, D Nagi, TH Jones; on behalf of the Association of
More informationCorrelation of Aging and Body Mass Index with the Hypothalamic- Pituitary-Gonadal Axis Hormones in Men, with Diabetes Mellitus
6 The Open Andrology Journal, 2010, 2, 6-10 Open Access Correlation of Aging and Body Mass Index with the Hypothalamic- Pituitary-Gonadal Axis Hormones in Men, with Diabetes Mellitus Irinel Stanciu 1,3,
More informationTwenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency a prospective study
ORIGINAL Article Vol. 38 (4): 512-518, July - August, 2012 Twenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency a prospective study Carlos
More informationTestosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.
SUSTANON 250 Testosterone propionate, phenylpropionate, isocaproate and decanoate What is in this leaflet Please read this leaflet carefully before you start using SUSTANON 250. This leaflet answers some
More informationShalender Bhasin, MD. Glenn R Cunningham, MD. Mohit Khera, MD, MBA, MPH
Shalender Bhasin, MD Program Chair Professor of Medicine Boston University School of Medicine Section Chief Division of Endocrinology, Diabetes & Nutrition Boston, MA Glenn R Cunningham, MD Professor of
More informationKansas Behavioral Health Risk Bulletin
Kansas Behavioral Health Risk Bulletin Kansas Department of Health and Environment November 7, 1995 Bureau of Chronic Disease and Health Promotion Vol. 1 No. 12 Diabetes Mellitus in Kansas Diabetes mellitus
More informationANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM
ANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM AT A GLANCE First published in July 2003 by Andrology Australia 4th Edition, December
More informationWhat Each Vitamin & Mineral Does In Your Body. Vitamin A
What Each Vitamin & Mineral Does In Your Body Vitamin A Prevents skin disorders, such as acne, wrinkling and age spots. Enhances the immune system protects against colds, flu, and infections to kidney,
More informationAging Well - Part V. Hormone Modulation -- Growth Hormone and Testosterone
Aging Well - Part V Hormone Modulation -- Growth Hormone and Testosterone By: James L. Holly, MD (The Your Life Your Health article published in the December 4th Examiner was a first draft. It was sent
More informationHDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism
HDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism E. Bolu 1, A. Sonmez 1, S. Tapan 2, A. Taslipinar 1, A. Aydogdu 1, C. Meric 1, Y. Basaran 1, G. Uckaya 1, M. Serdar
More informationHEALTH UPDATE. Polycystic Ovary Syndrome (PCOS)
HEALTH UPDATE PO Box 800760 Charlottesville, VA 22908 Gynecology: (434) 924-2773 Polycystic Ovary Syndrome (PCOS) What is it? An endocrine (hormonal) disorder. Because there is such variability in how
More informationHuman Testosterone EIA Kit
Human Testosterone EIA Kit CATALOG NO: IRAAKT2538 LOT NO: SAMPLE INTENDED USE The Testosterone Immunoassay kit uses a specifically generated antibody to measure testosterone and its metabolites in urine
More informationCOULD IT BE LOW TESTOSTERONE?
COULD IT BE LOW TESTOSTERONE? By Dr. Lauren M. Bramley For thousands of years women have been recognized for their sensitivity to hormones. PMS, post partum depression, menopause have long been plights
More informationTestosterone Replacement Therapy and Prostate Risks: Where s the Beef?
Testosterone Replacement Therapy and Prostate Risks: Where s the Beef? Abraham Morgentaler, MD Division of Urology Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts, USA
More informationTestosterone. Testosterone For Women
Testosterone Testosterone is a steroid hormone. Popular use of the term steroid leads people to believe that it signifies a drug that s illegal and abused by some body builders and other athletes. While
More informationHow To Know If You Can Lose Weight
ATTACHMENT: Useful remarks for patient and doctor, to be associated to the analytical results. Your doctor should interpret this report. Cod. ID: 123456 CCV: 000 Date: 01/01/2014 Patient: Rossi Mario Rapport
More informationDiabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationLou Haenel, IV, DO Endocrinology October 3, 2015 TESTOSTERONE AND MALE HYPOGONADISM : DECIDING WHEN TO TREAT
Lou Haenel, IV, DO Endocrinology October 3, 2015 TESTOSTERONE AND MALE HYPOGONADISM : DECIDING WHEN TO TREAT Figure 1 The hypothalamic pituitary gonadal axis in men and the impact of testosterone therapy
More informationEPILEPSY. & Men s Health
EPILEPSY & Men s Health HORMONAL EFFECTS in Men with Epilepsy Does epilepsy affect hormones? Yes, epilepsy is associated with hormonal changes. For instance, experts estimate that approximately 40 percent
More informationImproving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge
Improving drug prescription in elderly diabetic patients FRANCESC FORMIGA Hospital Universitari de Bellvitge High prevalence, but also increases the incidence. The older the patients, the higher the percentages
More informationOverview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
More informationregulation of ECF composition and volume regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon
Hormonal Effects regulation of ECF composition and volume ADH, aldosterone, ANF regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon regulation of muscle contraction
More informationCONSIDERATIONS BEFORE TESTOSTERONE THERAPY WHAT S UP WITH THE T?
CONSIDERATIONS BEFORE TESTOSTERONE THERAPY WHAT S UP WITH THE T? Emily Wood Demetriou, MD MMP Endocrinology and Diabetes ACP Conference September 26, 2015 -29 yo man presents to your clinic for hypogonadism
More informationPOSTMENOPAUSAL HYPERANDROGENEMIA (ANDROID OBESITY, INSULIN RESISTANCE, DIABETES MELLITUS) AND THERAPEUTIC CONSEQUENCES
MENOPAUSE ANDROPAUSE Postmenopausal Hyperandrogenemia 159 POSTMENOPAUSAL HYPERANDROGENEMIA (ANDROID OBESITY, INSULIN RESISTANCE, DIABETES MELLITUS) AND THERAPEUTIC CONSEQUENCES D. FOTH, TH. RÖMER POSTMENOPAUSAL
More informationChapter 2 Pathophysiology of Late-Onset Hypogonadism and Risks and Benefits of Replacement Therapy
Chapter 2 Pathophysiology of Late-Onset Hypogonadism and Risks and Benefits of Replacement Therapy Peter Huat Chye Lim Introduction The testosterone molecule is depicted below (Fig. 2.1 ). Testosterone
More informationCalcium. Table 1: Difference between method means in percent
Calcium Measurement of total calcium is widely used for both the diagnosis and the monitoring of a range of conditions related to the bones, heart, nerves, and kidneys. Total calcium measurements include
More informationProtocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials. Version: 1. Date: 5 th December 2011
Protocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials Version: 1 Date: 5 th December 2011 Study team: C Mary Schooling, CUNY School of Public Health
More informationMALE HORMONES AND AGING. Too Much Estrogen
MALE HORMONES AND AGING Too Much Estrogen As men age past age 40, hormonal changes occur that perceptibly inhibit physical, sexual, and cognitive function. The outward appearance of a typical middle-aged
More informationab178663 Free Testosterone ELISA Kit
ab178663 Free Testosterone ELISA Kit Instructions for Use A competitive immunoenzymatic assay for the quantitative measurement of Free Testosterone in serum and plasma (citrate). This product is for research
More informationBonus Supplement plement Formula Testosterone Booster
The Muscle Nerd s Personal Testosterone Booster Recipe Goal: Naturally Increase Testosterone Levels For Increased Muscle Mass Supplement Recipe Ingredients: Zinc: 50mg (use only 25mg if also using my PM
More informationDiabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
More informationUnderstanding the long-term risks and benefits of testosterone replacement
Understanding the long-term risks and benefits of testosterone replacement Nathan Hale, DO Samuel Deem, DO SHUTTERSTOCK.COM Male hypogonadism, also called andropause and androgen deficiency of the aging
More informationTHE HYPOTHALAMIC-PITUITARY-GONADAL AXIS IN MALE PSYCHIATRIC INPATIENTS
THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS IN MALE PSYCHIATRIC INPATIENTS Bilyana Brdaroska A thesis submitted in accordance with the requirements for the admission to the degree of Doctor of Medicine of
More informationA STUDY OF MAGNESIUM SUPPLEMENTATION ON GLYCEMIC CONTROL IN PATIENTS OF TYPE-2 DIABETES MELLITUS
RESEARCH ARTICLE A STUDY OF MAGNESIUM SUPPLEMENTATION ON GLYCEMIC CONTROL IN PATIENTS OF TYPE-2 DIABETES MELLITUS Yogendra Raj Singh 1, Shilpi Verma 2, Dushyant Agrawal 3,*, Brijendra Singh 4, Ashutosh
More informationA list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.
FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke
More informationTestosterone EIA Kit User Manual
B-Bridge International, Inc. Testosterone EIA Kit User Manual Catalog# K3032-1 1 Plate Kit K3032-5 5 Plate Kit 1 TABLE OF CONTENTS Intended Use 3 Background 3 Assay Principle 3 Kit Components 4 Materials
More informationYour Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
More informationTalk to your doctor about low testosterone
Talk to your doctor about low testosterone Maybe he doesn t find me attractive any more? Maybe he needs to lose some weight? Maybe he s lost his spark? Bayer Pharma AG Müllerstraße 178 13353 Berlin Germany
More information